A Randomized Controlled Trial of Port Site Subcutaneous Injection of Bupivacaine to Determine the Effectiveness of Postoperative Pain Relief After Laparoscopic Cholecystectomy
试验速览
- 阶段
- 3 期
- 入组人数
- 166
- 主要终点
- Post laparoscopic port site pain assessment
研究概览
简要总结
To determine the effectiveness of port site bupivacaine infiltration in postoperative pain reduction after laparoscopic cholecystectomy.
详细描述
The study is being done to determine the effectiveness of port site bupivacaine infiltration in postoperative pain reduction after laparoscopic cholecystectomy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients of both the gender of age >18 years and <45years
- •Patients undergoing elective laparoscopic cholecystectomy under general anesthesia.
- •Patients with A.S.A grade I and II.
排除标准
- •Patients with known allergic reactions to local anesthetics.
- •Patients converted to open procedure.
- •Patients developing intra-operative complications.
- •Patients undergoing for laparoscopic cholecystectomy for acute cholecystitis.
- •Patients with obesity and chronic illness.
- •Patients with history of opioids, steroids, NSAIDs and alcohol use.
研究组 & 干预措施
Bupivacaine group
Patient receiving 20ml of inj. 0.25% Bupivacaine at laparoscopic port site
干预措施: 0.25% Bupivacaine (Drug)
结局指标
主要结局
Post laparoscopic port site pain assessment
时间窗: Pain assessment from 0hour (patient received in recovery room) till 12hours postoperatively at interval of 3hours i.e. 0,3,6,9,12 hour
Pain assessment by "Visual Analog Scoring system" scoring from 0 to 10, where 0 means no pain and 10 means worst possible, unbearable excruciating pain.
次要结局
未报告次要终点
研究者
Dr. Nida Shahid
Assistant Professor
Hamdard University